Granisetron shortage — IT supply status & alternatives

Granisetron

—

🇦🇺 AUST R 300322 · AFT Pharmaceuticals Pty Ltd

In supply · Australia

Granisetron Hydrochloride

In supply · 🇦🇺 Australia · short in🇮🇹 IT🇨🇦 CA

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$8.29details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Granisetron
Brand names	Granisetron Hydrochloride
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper
Controlled substance	No
Marketing-authorisation holders	AFT Pharmaceuticals Pty Ltd, HAMELN PHARMA LTD, Generics (UK) Limited, FRESENIUS KABI LIMITED +10 more
Registrations on file	25
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$8.29

AEMP

Dispensed (DPMQ)

—

incl. fees

Pack

granisetron 2 mg tablet, 1

Source: PBSEffective July 2026 · AUD

Other markets

🇺🇸 US

US$1.12

Acquisition

🇫🇷 FR

€13.00

Retail price

🇪🇸 ES

€47.99

Retail price

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~1 month

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

15 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Wockhardt LTDSyn-Tech Chem And Pharm CO LTDWavelength Enterprises LTDChongqing Carelife Pharmaceutical CO LTDInke SACipla LTD+9 more

Manufacturing countries: India, Taiwan, Israel, China, Spain, Jordan · Source: FDA List of Drug Master Files

FDA-approved products 🇺🇸 Drugs@FDA

Approved applications

Generic (ANDA)

Brand (NDA/BLA)

Feb 2026

Latest approval

Shortage status by regulator official notices

🇮🇹

Italy

AIFA · 7h ago

Critical

🇨🇦

Canada

HC · just now

High

🇪🇸

Spain

AEMPS · 1mo ago

Resolved

Recalls official enforcement reports

🇺🇸

Granisetron

Infusion Options, Inc. · June 2019

Class IIdetails ↗

Verified timeline regulator events

🇨🇦 1 May 2026

high reported

🇪🇸 24 Mar 2026

Shortage resolved

🇨🇦 4 Feb 2026

high reported

🇮🇹 11 Dec 2025

critical reported

🇨🇦 10 Jan 2023

medium reported

Sources official regulators

🇨🇦

verified just now

verify ↗

🇮🇹

AIFA

verified 7h ago

verify ↗

🇪🇸

AEMPS

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders25 registrations · 14 MA holders

Product	Strength	Form	Market	MA holder	Status
Aft	3 mg	—	🇦🇺 AU	AFT Pharmaceuticals Pty Ltd	Active
GRANISETRON 1 MG/ML CONCENTRATE FOR SOLUTION FOR INJECTION OR INFUSION	1 MG	injection	🇬🇧 GB	HAMELN PHARMA LTD	Active
GRANISETRON 1MG TABLETS	1MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
GRANISETRON 1MG/ML SOLUTION FOR INJECTION	1MG	injection	🇬🇧 GB	FRESENIUS KABI LIMITED	Active
GRANISETRON 1 MG FILM COATED TABLETS	1 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
GRANISETRON 2 MG FILM COATED TABLETS	2 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
GRANISETRON 1 MG FILM-COATED TABLETS	1 MG	tablet	🇬🇧 GB	DAWA LIMITED	Active
GRANISETRON 2 MG FILM-COATED TABLETS	2 MG	tablet	🇬🇧 GB	DAWA LIMITED	Active
GRANISETRON 1MG FILM-COATED TABLETS	1MG	tablet	🇬🇧 GB	TORRENT PHARMA (UK) LTD	Active
GRANISETRON 2MG FILM-COATED TABLETS	2MG	tablet	🇬🇧 GB	TORRENT PHARMA (UK) LTD	Active
GRANISETRON 1MG/1ML CONCENTRATE FOR SOLUTION FOR INFUSION OR INJECTION	1MG	injection	🇬🇧 GB	TORRENT PHARMA (UK) LTD	Active
GRANISETRON 3MG/3ML CONCENTRATE FOR SOLUTION FOR INFUSION OR INJECTION	3MG	injection	🇬🇧 GB	TORRENT PHARMA (UK) LTD	Active
Granisetron Hydrochloride	1mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Kabi	3 mg	—	🇦🇺 AU	Fresenius Kabi Australia Pty Ltd	Active
Kabi	1 mg	—	🇦🇺 AU	Fresenius Kabi Australia Pty Ltd	Active

+10 more registrations on file

Mederti Drug Report

Generated 4 July 2026 · Australia market · 3 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.